Publications by Sara Strzok

Peer-reviewed publications

  1. Strzok S, Cleanthous S, Pompilus F, Cano SJ, Marquis P, Cohan S, et al. Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study. Multiple Sclerosis Journal. 2018;4(2):2055217318783766.
  2. Simon A, Pompilus F, Querbes W, Wei A, Strzok S, Penz C, et al. Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations. The Patient – Patient-Centered Outcomes Research. 2018.
  3. Cleanthous S, Strzok S, Pompilus F, Cano S, Marquis P, Cohan S, et al. Addressing the targeting range of the ABILHAND-56 in relapsing–remitting multiple sclerosis: A mixed methods psychometric study. Multiple Sclerosis Journal – Experimental, Translational and Clinical. 2018;4(2):2055217318776990.

 

Posters

  1. Simon A, Pompilus F, Querbes W, Penz C, Agarwal S, Strzok S, et al. A qualitative analysis of disease burden in patients with acute intermittent porphyria and recurrent attacks. ISPOR; Boston, MA, USA, 2017.
  2. Petrillo J, Cadavid D, Castrillo-Viguera C, Cleanthous S, Pompilus F, Strzok S, et al. Expanding Our Understanding of Daily Life Activity Impact in Patients with Multiple Sclerosis. 7th Joint ECTRIMS-ACTRIMS Meeting; Paris, France, 2017.
  3. Karagiannis T, Marquis P, Petersen J, Meyers OI, Chui SY, Campbell AK, Strzok S, Pompilus F, Piault E. Understanding patients’ ability to function in order to inform clinical benefit in oncology studies. ISPOR; Glasgow, UK, 2017.
  4. Chen SY, Strzok S, Cleanthous S, Pompilus F, Cano S, Marquis P, et al. Development of a Gait Module to Complement the 12-item Patient-Reported Multiple Sclerosis Walking Scale. American Academy of Neurology 2017 – 69th Annual Meeting; Boston, MA, USA, 2017.
  5. Chen SY, Pompilus F, Strzok S, Cleanthous S, Cano S, Marquis P, et al. Patient-Reported Outcome Measurement in Manual Ability for Multiple Sclerosis: Addressing the Targeting Issues of the ABILHAND (P3. 364). American Academy of Neurology Boston, MA, USA, 2017.
  6. Bell JA, Pompilus F, Galaznik A, Strzok S, Bejar R, Fram RJ, et al. Enhancing the Content of the EORTC QLQ-C30 to Maximize the Detection of Treatment Benefit in Hematological Stem Cell Disorders Using the EORTC Item Library. American Society of Hematology annual meeting; Atlanta, GA, USA, 2017.
  7. Bell JA, Galaznik A, Pompilus F, Strzok S, Fram RJ, Faller DV, et al. Patient Perspectives on Symptom Experience and Impact on Health-Related Quality of Life in Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Low-Blast Acute Myeloid Leukemia. American Society of Hematology annual meeting; Atlanta, GA, USA, 2017.
  8. Chen SY, Pompilus F, Strzok S, Cleanthous S, Cano S, Marquis P, et al. Development of a Conceptual Framework for Daily Life Activities in Patients with Early Stage Relapsing-Remitting Multiple Sclerosis. 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis; London, UK, 2016.